Stefania Girotto
Structural Biophysics And Translational Pharmacology
Telefono
+39 010 2896 983
Research center
CCT@Morego
Biografia
All Publications
2022
Demuro S., Sauvey C., Tripathi S.K., Di Martino R.M.C., Shi D., Ortega J.A., Russo D., Balboni B., Giabbai B., Storici P., Girotto S., Abagyan R., Cavalli A.
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
European Journal of Medicinal Chemistry, vol. 229
2022
Romeo E., Saccoliti F., Liessi N., Armirotti A., Pastorino C., Pedemonte N., Girotto S., Bandiera T., Bertozzi F.
Characterization of corrector ARN23765 mechanism of action via Photo-Affinity Labeling (PAL) approach (FFC#4/2020)
XX Convention of FFC Investigators in Cystic Fibrosis
Poster
Conference
2022
Barbieri F., Bosio A.G., Pattarozzi A., Tonelli M., Bajetto A., Verduci I., Cianci F., Cannavale G., Palloni L.M.G., Francesconi V., Thellung S., Fiaschi P., Mazzetti S., Schenone S., Balboni B., Girotto S., Malatesta P., Daga A., Zona G., Mazzanti M., Florio T.
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
Journal of Experimental and Clinical Cancer Research, vol. 41, (no. 1)
2022
Balboni B., Tripathi S.K., Veronesi M., Russo D., Penna I., Giabbai B., Bandiera T., Storici P., Girotto S., Cavalli A.
Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays
International Journal of Molecular Sciences, vol. 23, (no. 7)
2022
Bagnolini G., Balboni B., Schipani F., Gioia D., Veronesi M., De Franco F., Kaya C., Jumde R.P., Ortega J.A., Girotto S., Hirsch A.K.H., Roberti M., Cavalli A.
Identification of RAD51-BRCA2 Inhibitors Using N-Acylhydrazone-Based Dynamic Combinatorial Chemistry
ACS Medicinal Chemistry Letters, vol. 13, (no. 8), pp. 1262-1269
Colleagues of Structural Biophysics And Translational Pharmacology